TruBridge, Inc. (TBRG)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$26.240.00%
Close 2026-07-10 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · TBRG
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -39.8% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 4.7% |
Growth built into the price is above our model estimate.
The price assumes 44.5 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 22 industry peers · Company calendar date is not available
TBRG — officer change
Dated 2026-07-09
Directors changed due to a merger, but officers continued serving.
Why it matters: Meeting regulatory rules is key for the merger to succeed and for future work.
Watch forTruBridge follows all rules on time. There are no delays.
Also watch forTruBridge might have problems with rules or delays. This could affect the merger.
Why it matters: This merger is key to TruBridge's growth strategy. Successful integration can boost revenue and market position.
Supportive ifThe merger is done. Integration goals are met in the next quarter.
Worry ifThere are integration problems or the merger is delayed.
Why it matters: Higher net income shows progress. This can bring in more investors.
Supportive ifQ2 net income is positive or much better than Q1.
Worry ifNet income remains negative or worsens compared to Q1.
Why it matters: The merger is key for TruBridge's future as a subsidiary of IKS Health. It impacts operations and market position.
Supportive ifThe merger closes successfully by the end of Q3 2026 with all conditions met.
Worry ifThe merger may be delayed or fail. This can happen due to unmet rules or shareholder needs.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$19 on $10,000 · ±0.2% | How much price usually moves either way. |
| Bad day | $364 loss on $10,000 · 3.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,065 loss on $10,000 · 40.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Changes in listing status can affect stock trading and how investors see it.
Worry ifTruBridge gets confirmation to stay listed on Nasdaq after the merger.
Less concerning ifTruBridge gets a delisting notice from Nasdaq after the merger.
Why it matters: This acquisition could enhance growth and market position. Delays may signal challenges.
Supportive ifThe purchase is done.
Worry ifThe purchase is delayed or canceled.
Why it matters: If revenue growth in the healthcare sector picks up, it could boost TruBridge's performance. This is crucial as the sector is maturing.
Supportive ifHealthcare sector revenue growth is speeding up again. It is moving toward 10% or more.
Worry ifHealthcare sector revenue growth remains below 5%.
Why it matters: The merger will change how TruBridge works. It will also change its place in the market.
Supportive ifThe merger is complete. TruBridge becomes a wholly owned part of IKS Health.
Worry ifThe merger is delayed or fails. This affects TruBridge's future plans.
Why it matters: Legal cases could affect TruBridge's work and finances. Good news may reduce worries.
Worry ifGood court decisions or settlements are announced.
Less concerning ifBad rulings or higher legal costs come up.
Why it matters: Shareholder approval is crucial for completing the merger. If approved, it confirms investor support for the deal.
Supportive ifShareholders approve the merger. This lets the transaction close as planned.
Worry ifShareholders deny approval. This causes the merger to fail.
Why it matters: Earnings results will show if the company can maintain its recent momentum. Investors will look for revenue growth trends.
Watch forQ2 earnings report shows revenue growth above 10% year over year.
Also watch forQ2 earnings report shows revenue growth below 5% year over year.
Why it matters: Lawsuits could delay or stop the merger. This impacts shareholder value and operations.
Worry ifNo new lawsuits are filed against the merger. This allows it to proceed smoothly.
Less concerning ifNew lawsuits challenge the merger. This causes delays.
Why it matters: The merger needs approval to finalize. Delays can change the timeline and operations.
Supportive ifRegulators approve the merger without conditions. This allows it to move forward.
Worry ifApproval is delayed or denied. This affects the merger timeline.
Why it matters: Keeping revenue steady is important for investor trust. It shows the company can handle changes.
Supportive ifQ2 revenue reported at or above $86M.
Worry ifQ2 revenue drops below $85M. This shows instability.
Why it matters: If TruBridge buys companies, it shows they are growing. This helps their plans for growth.
Supportive ifLook for news about another acquisition that fits their goals.
Worry ifNo new acquisitions announced or completed in the next quarter.